Contact this trialFirst, we need to learn more about you.
Corticosteroid
Crinecerfont for Congenital Adrenal Hyperplasia
Recruiting1 awardPhase 3
Dallas, Texas
This trial is testing a new drug for people with classic CAH due to 21-hydroxylase deficiency. The trial will last about 20 months and will compare the new drug to a placebo.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.